Exploration of Targeted Anti-tumor Therapy

Open Access Review

Antibody-drug conjugates: beyond current approvals and potential future strategies

Siddharth Menon ... Hui K. Gan

Published: April 28, 2022 Explor Target Antitumor Ther. 2022;3:252–277

DOI: https://doi.org/10.37349/etat.2022.00082

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

9809 258 18

Open Access Perspective

Endocrine resistant breast cancer: brain metastasis

Matthew Willman ... Brandon Lucke-Wold

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:240–251

DOI: https://doi.org/10.37349/etat.2022.00081

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

3398 47 11

Open Access Original Article

The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer

Samuel Jones ... Kathryn M. Taylor

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:224–239

DOI: https://doi.org/10.37349/etat.2022.00080

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

4526 92 2

Open Access Review

Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy

Marianeve Carotenuto ... Nicola Normanno

Published: April 26, 2022 Explor Target Antitumor Ther. 2022;3:200–223

DOI: https://doi.org/10.37349/etat.2022.00079

This article belongs to the special issue Precision Medicine for Cholangiocarcinoma

Full Text PDF

7035 104 21

Open Access Review

Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic

Aglaia Skolariki ... Simon Lord

Published: April 24, 2022 Explor Target Antitumor Ther. 2022;3:172–199

DOI: https://doi.org/10.37349/etat.2022.00078

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

6017 106 15

Open Access Review

Advancing antibody-drug conjugates in gynecological malignancies: myth or reality?

Marta Nerone ... Ilaria Colombo

Published: April 19, 2022 Explor Target Antitumor Ther. 2022;3:149–171

DOI: https://doi.org/10.37349/etat.2022.00077

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

7148 145 5

Open Access Review

Yeast as a tool to decipher the molecular mechanisms underlying the functions of Bcl-2 family

Stéphen Manon

Published: April 02, 2022 Explor Target Antitumor Ther. 2022;3:128–148

DOI: https://doi.org/10.37349/etat.2022.00076

This article belongs to the special issue The Role of Bcl-2 Family Proteins in Cancer Progression and Their Relevance to Cancer Therapy

Full Text PDF

3287 49 7

Open Access Review

Polyester materials for mRNA delivery

Wang Chen ... Dandan Zhu

Published: March 11, 2022 Explor Target Antitumor Ther. 2022;3:117–127

DOI: https://doi.org/10.37349/etat.2022.00075

This article belongs to the special issue Gene Delivery Approach to Fight Cancer

Full Text PDF

4238 133 9